Jay S. Duker
CIK: 0001630864
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EyePoint, Inc.
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Jul 10, 2026EYPT
EyePoint, Inc.
Tax Payment(F)Direct8.1K shares at avg. $14.72$119K - Jul 10, 2026EYPT
EyePoint, Inc.
Exercise(M)Direct16.7K shares- - Mar 23, 2026EYPT
EyePoint, Inc.
Other(J)Direct76.8K shares at avg. $13.11$1.0M - Mar 23, 2026EYPT
EyePoint, Inc.
Other(J)Indirect76.8K shares at avg. $13.11$1.0M - Mar 16, 2026EYPT
EyePoint, Inc.
Purchase(P)Indirect1.5K shares at avg. $13.15$20K - Jan 6, 2026EYPT
EyePoint, Inc.
Tax Payment(F)Direct10.1K shares at avg. $16.86$170K - Jan 6, 2026EYPT
EyePoint, Inc.
Exercise(M)Direct20.8K shares- - Jan 5, 2026EYPT
EyePoint, Inc.
Tax Payment(F)Direct14.5K shares at avg. $17.43$253K - Jan 5, 2026EYPT
EyePoint, Inc.
Exercise(M)Direct30K shares- - Jan 3, 2026EYPT
EyePoint, Inc.
Exercise(M)Direct65K shares- - Jan 3, 2026EYPT
EyePoint, Inc.
Tax Payment(F)Direct23.4K shares at avg. $17.48$410K - Jan 2, 2026EYPT
EyePoint, Inc.
Award(A)DirectRestricted Stock Units
165K shares- - Jan 2, 2026EYPT
EyePoint, Inc.
Award(A)DirectStock Option (Right to Buy)
331K shares- - Jul 10, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Exercise(M)Direct16.7K shares- - Jul 10, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Tax Payment(F)Direct7.7K shares at avg. $11.06$85K - Jun 23, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Other(J)Direct56.7K shares at avg. $8.21$465K - Mar 19, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Other(J)Direct20K shares at avg. $6.16$123K - Feb 9, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Tax Payment(F)Direct2.1K shares at avg. $6.50$13K - Feb 9, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Exercise(M)Direct7K shares- - Jan 6, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Tax Payment(F)Direct6.1K shares at avg. $8.68$53K - Jan 6, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Exercise(M)Direct20.8K shares- - Jan 5, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Tax Payment(F)Direct10K shares at avg. $8.26$83K - Jan 5, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Exercise(M)Direct30K shares- - Jan 3, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
195K shares- - Jan 3, 2025EYPT
EyePoint Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
390K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 10, 2026 | EYPT EyePoint, Inc. | Tax Payment(F) | 8,059 | $14.72 | $118,628 | Direct |
| Jul 10, 2026 | EYPT EyePoint, Inc. | Exercise(M) | 16,667 | - | $0 | Direct |
| Mar 23, 2026 | EYPT EyePoint, Inc. | Other(J) | 76,766 | $13.11 | $1,006,402 | Direct |
| Mar 23, 2026 | EYPT EyePoint, Inc. | Other(J) | 76,766 | $13.11 | $1,006,402 | Indirect |
| Mar 16, 2026 | EYPT EyePoint, Inc. | Purchase(P) | 1,500 | $13.15 | $19,724 | Indirect |
| Jan 6, 2026 | EYPT EyePoint, Inc. | Tax Payment(F) | 10,054 | $16.86 | $169,510 | Direct |
| Jan 6, 2026 | EYPT EyePoint, Inc. | Exercise(M) | 20,793 | - | $0 | Direct |
| Jan 5, 2026 | EYPT EyePoint, Inc. | Tax Payment(F) | 14,505 | $17.43 | $252,822 | Direct |
| Jan 5, 2026 | EYPT EyePoint, Inc. | Exercise(M) | 30,000 | - | $0 | Direct |
| Jan 3, 2026 | EYPT EyePoint, Inc. | Exercise(M) | 65,000 | - | $0 | Direct |
| Jan 3, 2026 | EYPT EyePoint, Inc. | Tax Payment(F) | 23,447 | $17.48 | $409,854 | Direct |
| Jan 2, 2026 | EYPT EyePoint, Inc. | Award(A) Restricted Stock Units | 165,000 | - | - | Direct |
| Jan 2, 2026 | EYPT EyePoint, Inc. | Award(A) Stock Option (Right to Buy) | 331,000 | - | - | Direct |
| Jul 10, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Exercise(M) | 16,667 | - | - | Direct |
| Jul 10, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Tax Payment(F) | 7,688 | $11.06 | $85,029 | Direct |
| Jun 23, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Other(J) | 56,665 | $8.21 | $465,220 | Direct |
| Mar 19, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Other(J) | 20,000 | $6.16 | $123,100 | Direct |
| Feb 9, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Tax Payment(F) | 2,055 | $6.50 | $13,347 | Direct |
| Feb 9, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Exercise(M) | 7,000 | - | - | Direct |
| Jan 6, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Tax Payment(F) | 6,108 | $8.68 | $53,017 | Direct |
| Jan 6, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Exercise(M) | 20,794 | - | $0 | Direct |
| Jan 5, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Tax Payment(F) | 10,007 | $8.26 | $82,658 | Direct |
| Jan 5, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Exercise(M) | 30,000 | - | $0 | Direct |
| Jan 3, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 195,000 | - | - | Direct |
| Jan 3, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 390,000 | - | - | Direct |
1-25 of 25 transactions
About Duker Jay S.
Duker Jay S. (SEC CIK 0001630864) files insider reports with the SEC as President and CEO of EyePoint, Inc. (EYPT).
Signal8 holds 10 ownership filings by Duker Jay S., all Form 4s, filed between Jan 7, 2025 and Jul 14, 2026. Those filings report 25 transactions, from Jan 3, 2025 to Jul 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Duker Jay S.'s filings is in WATERTOWN, MA.
Recent filings by Duker Jay S.
- Jul 10, 2026: Tax withholding of EYPT shares (Form 4, code F).
- Jul 10, 2026: Option exercise of EYPT shares (Form 4, code M).
- Mar 23, 2026: Other transactions of EYPT shares (2 lines, Form 4, code J).
- Mar 16, 2026: Open-market purchase of EYPT shares (Form 4, code P).
- Jan 6, 2026: Tax withholding of EYPT shares (Form 4, code F).
Other insiders filing for EyePoint, Inc. (EYPT)
- Elston George, Chief Financial Officer
- Zaderej Karen L., Director
- Ribeiro Ramiro, Chief Medical Officer
- Lurker Nancy, Director
- Sanders Reginald J., Director
- Landis John B., Director